Protocol: CDISCPILOT01                                                                  Page  1 of 5 
Population: Safety 
Table 14-7.01 
Summary of Vital Signs at Baseline and End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
Systolic Blood 
Pressure(mmHg) 
AFTER LYING DOWN 
FOR 5 MINUTES 
 Placebo 86 Baseline 
85 138.6 16.75 140.0  90.0 180.0 
 
 
 
 Week 24 
59 135.8 17.30 131.0 100.0 180.0 
 
 
 
 End of Trt. 84 136.7 18.30 134.0 100.0 180.0 
 
 
 
 Xan.Low 84 Baseline 
84 138.8 16.55 138.0 100.0 178.0 
 
 
 
 Week 24 
27 134.1 16.74 136.0 100.0 173.0 
 
 
 
 End of Trt. 84 135.7 17.17 134.0 100.0 190.0 
 
 
 
 Xan.High 84 Baseline 
84 140.1 17.82 141.0 100.0 188.0 
 
 
 
 Week 24 
30 132.2 18.18 130.0 101.0 178.0 
 
 
 
 End of Trt. 82 134.0 17.86 130.0 101.0 178.0 
 
 
AFTER STANDING 
FOR 1 MINUTE 
 Placebo 86 Baseline 
85 135.3 17.89 134.0  90.0 180.0 
 
 
 
 Week 24 
59 133.5 19.23 130.0  90.0 199.0 
 
 
 
 End of Trt. 84 133.9 18.68 130.5  90.0 199.0 
 
 
 
 Xan.Low 84 Baseline 
84 135.6 18.04 136.0 100.0 186.0 
 
 
 
 Week 24 
27 131.0 17.82 130.0  92.0 168.0 
 
 
 
 End of Trt. 84 132.8 17.53 130.0  92.0 180.0 
 
 
 
 Xan.High 84 Baseline 
84 137.3 19.71 138.0 100.0 194.0 
 
 
 
 Week 24 
30 130.4 20.83 128.0  96.0 198.0 
 
 
 
 End of Trt. 82 130.4 20.37 128.0  90.0 198.0 
 
 
AFTER STANDING 
FOR 3 MINUTES 
 Placebo 86 Baseline 
85 136.5 18.77 136.0  80.0 184.0 

--- Page 2 ---
Protocol: CDISCPILOT01                                                                  Page  2 of 5 
Population: Safety 
Table 14-7.01 
Summary of Vital Signs at Baseline and End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
 
 
 
 Week 24 
59 134.8 17.35 131.0 100.0 190.0 
 
 
 
 End of Trt. 84 134.1 18.01 130.0  90.0 190.0 
 
 
 
 Xan.Low 84 Baseline 
84 136.4 18.11 134.5 104.0 182.0 
 
 
 
 Week 24 
27 131.0 17.92 130.0 100.0 168.0 
 
 
 
 End of Trt. 83 133.1 17.80 130.0  98.0 200.0 
 
 
 
 Xan.High 84 Baseline 
84 138.8 18.75 138.0 100.0 186.0 
 
 
 
 Week 24 
30 129.2 16.95 126.0  90.0 172.0 
 
 
 
 End of Trt. 81 130.4 17.77 130.0  88.0 184.0 
 
Diastolic Blood 
Pressure(mmHg) 
AFTER LYING DOWN 
FOR 5 MINUTES 
 Placebo 86 Baseline 
85  75.7 11.09  76.0  40.0  99.0 
 
 
 
 Week 24 
59  72.9 11.32  74.0  44.0 109.0 
 
 
 
 End of Trt. 84  74.5 11.11  76.0  44.0 109.0 
 
 
 
 Xan.Low 84 Baseline 
84  76.3  9.77  76.0  57.0 100.0 
 
 
 
 Week 24 
27  76.1  9.14  76.0  60.0  90.0 
 
 
 
 End of Trt. 84  74.3  8.88  74.0  45.0  90.0 
 
 
 
 Xan.High 84 Baseline 
84  77.2  9.80  78.0  51.0  98.0 
 
 
 
 Week 24 
30  73.9  9.23  74.0  60.0  92.0 
 
 
 
 End of Trt. 82  74.1  9.27  74.0  56.0  94.0 
 
 
AFTER STANDING 
FOR 1 MINUTE 
 Placebo 86 Baseline 
85  77.9 10.63  78.0  51.0 104.0 
 
 
 
 Week 24 
59  74.2 12.89  74.0  45.0 117.0 
 
 
 
 End of Trt. 84  74.9 12.16  76.0  45.0 117.0 

--- Page 3 ---
Protocol: CDISCPILOT01                                                                  Page  3 of 5 
Population: Safety 
Table 14-7.01 
Summary of Vital Signs at Baseline and End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
 
 
 
 Xan.Low 84 Baseline 
84  76.2 10.14  78.0  54.0  98.0 
 
 
 
 Week 24 
27  76.3 10.28  78.0  60.0  98.0 
 
 
 
 End of Trt. 84  75.0  9.34  75.0  51.0  98.0 
 
 
 
 Xan.High 84 Baseline 
84  78.1 10.77  78.0  56.0 108.0 
 
 
 
 Week 24 
30  74.9 11.00  76.0  50.0  97.0 
 
 
 
 End of Trt. 82  75.9 11.77  76.5  48.0 112.0 
 
 
AFTER STANDING 
FOR 3 MINUTES 
 Placebo 86 Baseline 
85  77.7 11.00  78.0  46.0 110.0 
 
 
 
 Week 24 
59  74.3 11.38  74.0  51.0 110.0 
 
 
 
 End of Trt. 84  75.0 11.19  74.5  51.0 110.0 
 
 
 
 Xan.Low 84 Baseline 
84  76.6 10.93  76.0  48.0 108.0 
 
 
 
 Week 24 
27  76.2 10.18  76.0  57.0  98.0 
 
 
 
 End of Trt. 83  74.9  9.66  74.0  57.0 102.0 
 
 
 
 Xan.High 84 Baseline 
84  79.6 10.19  80.0  51.0 104.0 
 
 
 
 Week 24 
30  76.0 10.63  78.5  50.0  98.0 
 
 
 
 End of Trt. 81  76.8 11.71  78.0  50.0 118.0 
 
Pulse(bpm) 
AFTER LYING DOWN 
FOR 5 MINUTES 
 Placebo 86 Baseline 
85  70.4 10.46  70.0  51.0 100.0 
 
 
 
 Week 24 
59  69.1  9.46  68.0  50.0  92.0 
 
 
 
 End of Trt. 84  69.3  9.42  68.5  50.0  92.0 
 
 
 
 Xan.Low 84 Baseline 
84  68.8  9.52  68.0  50.0  88.0 

--- Page 4 ---
Protocol: CDISCPILOT01                                                                  Page  4 of 5 
Population: Safety 
Table 14-7.01 
Summary of Vital Signs at Baseline and End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
 
 
 
 Week 24 
27  68.1  9.28  68.0  52.0  90.0 
 
 
 
 End of Trt. 84  67.8 10.55  68.0  48.0 100.0 
 
 
 
 Xan.High 84 Baseline 
84  70.1  9.27  68.0  52.0  98.0 
 
 
 
 Week 24 
30  69.3 11.88  68.0  47.0  96.0 
 
 
 
 End of Trt. 82  68.1 11.27  68.0  47.0 100.0 
 
 
AFTER STANDING 
FOR 1 MINUTE 
 Placebo 86 Baseline 
85  75.5 12.68  76.0  56.0 133.0 
 
 
 
 Week 24 
59  72.8  8.98  74.0  52.0  88.0 
 
 
 
 End of Trt. 84  73.5  9.09  74.0  52.0  96.0 
 
 
 
 Xan.Low 84 Baseline 
84  73.5 10.59  72.0  53.0 100.0 
 
 
 
 Week 24 
27  72.1  9.53  74.0  52.0  88.0 
 
 
 
 End of Trt. 84  73.0 10.84  73.0  51.0 104.0 
 
 
 
 Xan.High 84 Baseline 
84  75.0 10.89  72.0  56.0 104.0 
 
 
 
 Week 24 
30  73.4 11.93  72.0  54.0  98.0 
 
 
 
 End of Trt. 82  72.6 11.11  71.0  52.0 100.0 
 
 
AFTER STANDING 
FOR 3 MINUTES 
 Placebo 86 Baseline 
85  74.6 11.94  74.0  54.0 134.0 
 
 
 
 Week 24 
59  72.8  8.73  74.0  56.0  88.0 
 
 
 
 End of Trt. 84  73.4  9.08  74.0  56.0  98.0 
 
 
 
 Xan.Low 84 Baseline 
84  72.3 10.99  70.0  51.0 104.0 
 
 
 
 Week 24 
27  70.7 10.78  72.0  52.0  96.0 
 
 
 
 End of Trt. 83  71.6 10.42  72.0  52.0  97.0 

--- Page 5 ---
Protocol: CDISCPILOT01                                                                  Page  5 of 5 
Population: Safety 
Table 14-7.01 
Summary of Vital Signs at Baseline and End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
 
 
 
 Xan.High 84 Baseline 
84  74.0 10.76  72.0  52.0 100.0 
 
 
 
 Week 24 
30  72.4 11.92  71.5  54.0  96.0 
 
 
 
 End of Trt. 81  71.8 10.76  70.0  54.0 106.0 
 
 
